IQVIA Holdings Inc Cash Flow Conversion Efficiency

Latest as of June 2026: 0.089x

IQVIA Holdings Inc cash flow conversion efficiency. Based on the latest financial reports, IQVIA Holdings Inc (IQV) has a cash flow conversion efficiency ratio of 0.089x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($558.00 Million) by net assets ($6.30 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of IQVIA Holdings Inc (2011–2025)

Cash flow conversion efficiency of IQVIA Holdings Inc from 2011 to 2025. This chart illustrates how IQVIA Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View IQV stock price and chart for real-time trading data and today's change.

IQVIA Holdings Inc Cash Flow Conversion Ratio Explained

IQVIA Holdings Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

IQVIA Holdings Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of IQVIA Holdings Inc ranked by their cash flow conversion efficiency. Also see market value of IQVIA Holdings Inc for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Powszechna Kasa Oszczednosci Bank Polski SA
WAR:PKO
0.037x
RIO Tinto Ltd
AU:RIO
0.151x
Commerzbank AG
XETRA:CBK
-0.209x
CITIC LTD. ADR/5 HD-40
F:CPF0
N/A
Garmin Ltd
F:GEY
0.058x
Prudential plc
MX:PUKN
0.030x
Nokia Corp ADR
NYSE:NOK
0.018x
American International Group Inc
NYSE:AIG
0.004x

Annual Cash Flow Conversion Efficiency for IQVIA Holdings Inc (2011–2025)

The table below shows the annual cash flow conversion efficiency of IQVIA Holdings Inc from 2011 to 2025. Review cash generation quality of IQVIA Holdings Inc to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $6.63 Billion $2.65 Billion 0.400x -10.58%
2024-12-31 $6.07 Billion $2.72 Billion 0.448x +27.32%
2023-12-31 $6.11 Billion $2.15 Billion 0.352x -10.31%
2022-12-31 $5.76 Billion $2.26 Billion 0.392x -19.49%
2021-12-31 $6.04 Billion $2.94 Billion 0.487x +56.09%
2020-12-31 $6.28 Billion $1.96 Billion 0.312x +37.88%
2019-12-31 $6.26 Billion $1.42 Billion 0.226x +25.47%
2018-12-31 $6.95 Billion $1.25 Billion 0.180x +55.38%
2017-12-31 $8.36 Billion $970.00 Million 0.116x +19.57%
2016-12-31 $8.86 Billion $860.00 Million 0.097x +106.85%
2015-12-31 $-335.68 Million $475.69 Million -1.417x -131.07%
2014-12-31 $-704.01 Million $431.75 Million -0.613x -3.02%
2013-12-31 $-667.49 Million $397.37 Million -0.595x -141.01%
2012-12-31 $-1.36 Billion $335.70 Million -0.247x -48.80%
2011-12-31 $-969.60 Million $160.95 Million -0.166x --

About IQVIA Holdings Inc

NYSE:IQV USA Diagnostics & Research
Market Cap
$44.74 Billion
Market Cap Rank
#674 Global
#320 in USA
Share Price
$271.83
Change (1 day)
+2.62%
52-Week Range
$156.66 - $279.36
All Time High
$282.61
About

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment of… Read more